Susquehanna International Group
ABMD

Susquehanna International Group’s Abiomed Inc ABMD Stock Holding History

Susquehanna International Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,300
Closed -$2.78M – 14359
2022
Q3 		$2.78M Sell
11,300
-9,200
-45% -$2.48M ﹤0.01% 4238
2022
Q2 		$5.07M Buy
20,500
+2,100
+11% +$567K ﹤0.01% 3164
2022
Q1 		$6.09M Sell
18,400
-50,500
-73% -$15.5M ﹤0.01% 3314
2021
Q4 		$24.7M Buy
68,900
+6,100
+10% +$2.06M ﹤0.01% 1648
2021
Q3 		$20.4M Sell
62,800
-2,200
-3% -$745K ﹤0.01% 1943
2021
Q2 		$20.3M Buy
65,000
+8,800
+16% +$2.7M ﹤0.01% 2014
2021
Q1 		$17.9M Sell
56,200
-61,500
-52% -$19.7M ﹤0.01% 2007
2020
Q4 		$38.2M Buy
117,700
+2,800
+2% +$774K 0.01% 1187
2020
Q3 		$31.8M Buy
114,900
+17,100
+17% +$4.93M 0.01% 1140
2020
Q2 		$23.6M Sell
97,800
-172,300
-64% -$34.6M 0.01% 1285
2020
Q1 		$39.2M Sell
270,100
-341,600
-56% -$56.7M 0.01% 775
2019
Q4 		$104M Buy
611,700
+285,400
+87% +$52.9M 0.03% 467
2019
Q3 		$58M Buy
326,300
+70,500
+28% +$15.2M 0.02% 661
2019
Q2 		$66.6M Sell
255,800
-8,200
-3% -$2.18M 0.02% 558
2019
Q1 		$75.4M Buy
264,000
+93,300
+55% +$31M 0.03% 455
2018
Q4 		$55.5M Sell
170,700
-126,500
-43% -$43.9M 0.02% 565
2018
Q3 		$134M Buy
297,200
+113,900
+62% +$44.9M 0.04% 357
2018
Q2 		$75M Buy
183,300
+104,200
+132% +$37.7M 0.03% 508
2018
Q1 		$23M Buy
79,100
+15,300
+24% +$3.88M 0.01% 1116
2017
Q4 		$12M Buy
63,800
+28,700
+82% +$5.36M ﹤0.01% 1685
2017
Q3 		$5.92M Hold
35,100
– – ﹤0.01% 2296
2017
Q2 		$5.03M Sell
35,100
-11,800
-25% -$1.59M ﹤0.01% 2405
2017
Q1 		$5.87M Buy
46,900
+21,100
+82% +$2.45M ﹤0.01% 2190
2016
Q4 		$2.91M Sell
25,800
-22,100
-46% -$2.56M ﹤0.01% 3307
2016
Q3 		$6.16M Buy
47,900
+11,000
+30% +$1.32M ﹤0.01% 2007
2016
Q2 		$4.03M Sell
36,900
-38,800
-51% -$3.86M ﹤0.01% 2490
2016
Q1 		$7.18M Buy
75,700
+18,400
+32% +$1.55M ﹤0.01% 1866
2015
Q4 		$5.17M Buy
57,300
+36,400
+174% +$3.09M ﹤0.01% 2504
2015
Q3 		$1.94M Sell
20,900
-12,200
-37% -$1.07M ﹤0.01% 4345
2015
Q2 		$2.18M Sell
33,100
-11,700
-26% -$777K ﹤0.01% 4533
2015
Q1 		$3.21M Buy
44,800
+38,000
+559% +$2.06M ﹤0.01% 3434
2014
Q4 		$259K Buy
+6,800
New +$214K ﹤0.01% 8379
2014
Q3 		– Sell
-8,200
Closed -$206K – 10096
2014
Q2 		$206K Sell
8,200
-3,300
-29% -$76.8K ﹤0.01% 9014
2014
Q1 		$299K Buy
11,500
+3,800
+49% +$105K ﹤0.01% 7590
2013
Q4 		$206K Sell
7,700
-10,600
-58% -$262K ﹤0.01% 8227
2013
Q3 		$349K Buy
18,300
+8,500
+87% +$194K ﹤0.01% 6989
2013
Q2 		$211K Buy
+9,800
New +$197K ﹤0.01% 7351

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's ABMD Position: Q4 2022 in Review

Susquehanna International Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 971 shares — an estimated $239K sold.

Susquehanna International Group first reported a position in ABMD in Q3 2013 and held it in 34 quarters. The position peaked at $29.9M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Susquehanna International Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 971 Abiomed Inc shares in Q4 2022, an estimated $239K.
  • Susquehanna International Group first reported a position in Abiomed Inc in Q3 2013 and held it in 34 quarters.
  • Susquehanna International Group's Abiomed Inc position peaked at $29.9M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.